Manchester United PLC vs Mesoblast Limited — how do they compare? Manchester United PLC trades at $22.23 (market cap $3.80B), while Mesoblast Limited trades at $16.68 (market cap $2.21B). The key difference: Manchester United PLC is the larger of the two by market cap, and Manchester United PLC pays a 1.26% dividend while Mesoblast Limited pays none. Which is the better fit depends on your goals.
| MANU | MESO | |
|---|---|---|
Market Cap | $3.80B | $2.21B |
Sector | Media | Technology |
52-Week High | $23.53 | $20.96 |
52-Week Low | $15.10 | $12.88 |
Enterprise Value | $4.74B | $2.21B |
Dividend Yield | 1.26% | — |
Trailing returns across standard periods
Manchester United PLC operates a professional football club together with related and ancillary activities. The company manages the soccer team and all affiliated club activities of the Manchester United Football Club, which includes the media network, foundation, fan zone, news, sports features, and team merchandise. Manchester United is based in England. The company has three principal sectors from which most of the revenue is generated, including Commercial, Broadcasting, and Matchday.
Read more on MANU →Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →